论文部分内容阅读
目的探讨专题讨论会对肺癌患者健康教育的效果。方法选取2013年1月至2015年12月间陕西省宝鸡市中心医院收治的564例肺癌患者,采用随机数字表法将患者平均分为试验组和对照组,每组282例。试验组患者在常规健康教育基础上加以专题讨论会教育,对照组患者采用口头教育结合知识讲座的常规健康教育。采用自制的患者健康教育效果评价表对患者进行比较分析。采用欧洲癌症研究与治疗组织生命质量测定量表、焦虑自量表(SAS)和抑郁自量表(SDS)对患者生活质量进行评价并加以比较,对患者术后并发症及住院时间进行比较,统计并比较患者对合理用药、定期复查等的依从性。结果试验组患者健康教育效果为(94.6±2.1)分,对照组患者为(87.2±1.8)分,两组比较差异有统计学意义(P<0.05)。试验组欧洲癌症研究与治疗组织生命质量测定量表中各项得分均比对照组高,差异均有统计学意义(均P<0.05)。试验组SAS和SDS得分均较对照组低,差异均有统计学意义(均P<0.05)。试验组术后肺部并发症发生率为18.4%,平均住院时间11.6 d,比对照组均处于低水平,差异均有统计学意义(均P<0.05)。试验组患者合理用药、定期复查等的依从性均高于对照组,差异均有统计学意义(均P<0.05)。结论专题讨论会有助于肺癌患者有效掌握健康教育知识,提高肺癌患者生活质量。
Objective To discuss the effect of symposium on health education of lung cancer patients. Methods From January 2013 to December 2015, 564 patients with lung cancer admitted to Baoji Central Hospital of Shaanxi Province were randomly divided into experimental group and control group with random number table method, with 282 cases in each group. Patients in the test group were given symposium education on the basis of routine health education, and patients in the control group were given oral health education and general health education on knowledge lectures. The self-made patient health education evaluation table was used for comparative analysis of patients. The quality of life of patients in European Cancer Research and Treatment Organization (SAS) was assessed and compared with SAS, SDS, comparisons of postoperative complications and length of hospital stay, Statistics and comparison of patients on the rational use of drugs, regular review of compliance. Results The result of the health education in the experimental group was (94.6 ± 2.1) points, while that in the control group was (87.2 ± 1.8) points, the difference between the two groups was statistically significant (P <0.05). The score in the European Organization for Research and Treatment of Cancer Life Quality Measurement Scale in the experimental group was higher than that in the control group, with significant differences (all P <0.05). SAS and SDS scores in the experimental group were lower than those in the control group, the differences were statistically significant (P <0.05). The incidence of postoperative pulmonary complications in the experimental group was 18.4% and the average length of hospital stay was 11.6 days, which were significantly lower than those in the control group (all P <0.05). The compliance of patients in trial group with reasonable medication and regular review were higher than those in control group (all P <0.05). Conclusion The symposium will help patients with lung cancer effectively master the knowledge of health education and improve the quality of life of patients with lung cancer.